|
|||||
|
|
Author response to: Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption |
|
| Authors: | MK Killie,J Kjeldsen-Kragh,A Husebekk,B Skogen,JA Olsen,& IS Kristiansen |
| Affiliation: | Department of Immunology and Transfusion Medicine, University Hospital of North Norway, Tromsø, Norway; Department of Immunology and Transfusion Medicine, Ullevål University Hospital, Oslo, Norway; Institute of Medical Biology, Medical Faculty, University of Tromsø, Tromsø, Norway; Institute of Community Medicine, Medical Faculty, University of Tromsø, Tromsø, Norway; Deparment of Health Management and Health Economics, University of Oslo, Oslo, Norway |
| Abstract: | |
| Keywords: | |